Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine
- PMID: 25483463
- PMCID: PMC5443053
- DOI: 10.4161/21645515.2014.970973
Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine
Abstract
Human Papillomavirus (HPV) is the main cause of cervical cancer, which is the second most severe cancer of women worldwide, particularly in developing countries. Although vaccines against HPV infection are commercially available, they are neither affordable nor accessible to women in low income countries e.g. Africa. Thus, alternative cost-effective vaccine production approaches need to be developed. This study uses tobacco plants to express pentameric capsomeres of HPV that have been reported to generate elevated immune responses against HPV. A modified HPV-16 L1 (L1_2xCysM) protein has been expressed as a fusion protein with glutathione-S-transferase (GST) in tobacco chloroplasts following biolistic transformation. In total 7 transplastomic lines with healthy phenotypes were generated. Site specific integration of the GST-L1_2xCysM and aadA genes was confirmed by PCR. Southern blot analysis verified homogenous transformation of all transplastomic lines. Antigen capture ELISA with the conformation-specific antibody Ritti01, showed protein expression as well as the retention of immunogenic epitopes of L1 protein. In their morphology, GST-L1 expressing tobacco plants were identical to wild type plants and yielded fertile flowers. Taken together, these data enrich knowledge for future development of cost-effective plant-made vaccines against HPV.
Keywords: ELISA, enzyme-linked immunosorbent assay; GST; GST, glutathione-s-transferase; HPV, human papillomavirus; HPV-16 L1; L1_2xCysM, modified L1 gene; PCR, polymerase chain reaction; Plant-made vaccines; VLPs, virus-like particles; aadA, aminoglycoside 3'-adenylyltransferase; capsomeres; cervical cancer; plastid transformation.
Figures




Similar articles
-
Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.Transgenic Res. 2011 Apr;20(2):271-82. doi: 10.1007/s11248-010-9415-4. Epub 2010 Jun 19. Transgenic Res. 2011. PMID: 20563641
-
Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes.Plant Biotechnol J. 2011 Aug;9(6):651-60. doi: 10.1111/j.1467-7652.2011.00612.x. Epub 2011 Mar 29. Plant Biotechnol J. 2011. PMID: 21447051
-
Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.Plant Biotechnol J. 2013 Oct;11(8):964-75. doi: 10.1111/pbi.12089. Epub 2013 Aug 7. Plant Biotechnol J. 2013. PMID: 23924054
-
Developments in L2-based human papillomavirus (HPV) vaccines.Virus Res. 2017 Mar 2;231:166-175. doi: 10.1016/j.virusres.2016.11.020. Epub 2016 Nov 23. Virus Res. 2017. PMID: 27889616 Free PMC article. Review.
-
Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13. doi: 10.1016/j.vaccine.2006.05.110. Epub 2006 Jun 23. Vaccine. 2006. PMID: 16949996 Review.
Cited by
-
Reconceptualizing cancer immunotherapy based on plant production systems.Future Sci OA. 2017 Jul 12;3(3):FSO217. doi: 10.4155/fsoa-2017-0018. eCollection 2017 Aug. Future Sci OA. 2017. PMID: 28884013 Free PMC article. Review.
-
Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.Front Immunol. 2018 Nov 12;9:2478. doi: 10.3389/fimmu.2018.02478. eCollection 2018. Front Immunol. 2018. PMID: 30483247 Free PMC article. Review.
-
Codon Optimization to Enhance Expression Yields Insights into Chloroplast Translation.Plant Physiol. 2016 Sep;172(1):62-77. doi: 10.1104/pp.16.00981. Epub 2016 Jul 27. Plant Physiol. 2016. PMID: 27465114 Free PMC article.
-
A CRR2-Dependent sRNA Sequence Supports Papillomavirus Vaccine Expression in Tobacco Chloroplasts.Metabolites. 2023 Feb 21;13(3):315. doi: 10.3390/metabo13030315. Metabolites. 2023. PMID: 36984756 Free PMC article.
-
Plastids: The Green Frontiers for Vaccine Production.Front Plant Sci. 2015 Nov 17;6:1005. doi: 10.3389/fpls.2015.01005. eCollection 2015. Front Plant Sci. 2015. PMID: 26635832 Free PMC article. Review.
References
-
- Munoz N, Bosch FX, Sanjose S, Herrero R, Castellsague X, Shah KV. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med 2003; 348: 518-527; PMID:12571259; http://dx.doi.org/ 10.1056/NEJMoa021641 - DOI - PubMed
-
- National Cancer Institute Cancer advances in focus: Cervical Cancer 2010; http://www.cancer.gov/cancertopics/factsheet/cancer-advances-in-focus/ce....
-
- Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Brit J Cancer 2003; 88(1): 63-73; PMID:12556961; http://dx.doi.org/ 10.1038/sj.bjc.6600688 - DOI - PMC - PubMed
-
- Bosch FX. Human papillomavirus: science and technologies for the elimination of cervical cancer. Expert Opin Pharmaco 2011; 12(14): 2189-204; http://dx.doi.org/ 10.1517/14656566.2011.596527 - DOI - PubMed
-
- Smith JS, Hoots B, Lindsay L, Keys J, Winer R, Clifford GM, Franceschi S. Human papilloma-virus type distribution in invasive cervical cancer & high grade cervical lesions. Int J Cancer 2007; 121: 621-32; PMID:17405118; http://dx.doi.org/ 10.1002/ijc.22527 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials